Please login to the form below

Not currently logged in
Email:
Password:

Stallergenes

This page shows the latest Stallergenes news and features for those working in and with pharma, biotech and healthcare.

Merck gets US green light for allergy immunotherapy

Merck gets US green light for allergy immunotherapy

Grastek is the second allergy immunotherapy (AIT) product to be cleared for marketing in the US after Stallergenes' Oralair, which was approved last month.

Latest news

  • FDA backs a brace of allergy immunotherapies FDA backs a brace of allergy immunotherapies

    Stallergenes recently signed a deal with Greer, granting the latter exclusive commercialisation rights to Oralair in the US. ... Meanwhile for Stallergenes - with annual sales of around 250m - the upside could be significant.

  • Inducing immunity

    Hot on the heels of Grazax is Stallergenes' Oralair Grasses, which is expected to be launched in Europe in 2007.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Stallergenes appoints Christian Chavy CEO Stallergenes appoints Christian Chavy CEO

    Christian Chavy has been appointed CEO of French biopharmaceutical company Stallergenes and will take over from Roberto Gradnik at the end of this month. . ... Stallergenes said Chavy's appointment would enable it to “pursue its strategy” and to its

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics